These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 21787818)
41. A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy. Paliwal SR; Paliwal R; Mishra N; Mehta A; Vyas SP Curr Cancer Drug Targets; 2010 May; 10(3):343-53. PubMed ID: 20370682 [TBL] [Abstract][Full Text] [Related]
42. Synthesis and in vitro evaluation of pH-sensitive PEG-I-dC16 block polymer micelles for anticancer drug delivery. Rongbin H; Lei X; Ying L; Xiangping D; Xuan C; Lanfang L; Cuiyun Y; Yanming C; Guotao T J Pharm Pharmacol; 2016 Jun; 68(6):751-61. PubMed ID: 27018539 [TBL] [Abstract][Full Text] [Related]
43. Bio-distribution and anti-tumor efficacy of PEG/PLA nano particles loaded doxorubicin. Yu JJ; Lee HA; Kim JH; Kong WH; Kim Y; Cui ZY; Park KG; Kim WS; Lee HG; Seo SW J Drug Target; 2007 May; 15(4):279-84. PubMed ID: 17487696 [TBL] [Abstract][Full Text] [Related]
44. Self-assembled micelles based on Chondroitin sulfate/poly (d,l-lactideco-glycolide) block copolymers for doxorubicin delivery. Zhang H; Xu J; Xing L; Ji J; Yu A; Zhai G J Colloid Interface Sci; 2017 Apr; 492():101-111. PubMed ID: 28073063 [TBL] [Abstract][Full Text] [Related]
45. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy. Gao D; Lo PC J Control Release; 2018 Jul; 282():46-61. PubMed ID: 29673646 [TBL] [Abstract][Full Text] [Related]
46. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery. Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665 [TBL] [Abstract][Full Text] [Related]
47. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. Wang J; Sun J; Chen Q; Gao Y; Li L; Li H; Leng D; Wang Y; Sun Y; Jing Y; Wang S; He Z Biomaterials; 2012 Oct; 33(28):6877-88. PubMed ID: 22770799 [TBL] [Abstract][Full Text] [Related]
48. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance. Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991 [TBL] [Abstract][Full Text] [Related]
49. Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. Xu W; Siddiqui IA; Nihal M; Pilla S; Rosenthal K; Mukhtar H; Gong S Biomaterials; 2013 Jul; 34(21):5244-53. PubMed ID: 23582862 [TBL] [Abstract][Full Text] [Related]
50. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin. Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461 [TBL] [Abstract][Full Text] [Related]
51. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release. Chen W; Zhong P; Meng F; Cheng R; Deng C; Feijen J; Zhong Z J Control Release; 2013 Aug; 169(3):171-9. PubMed ID: 23306022 [TBL] [Abstract][Full Text] [Related]
52. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay. Zhang C; Wu Y; Dong Y; Xu H; Zhao L Pharm Biol; 2016; 54(1):55-61. PubMed ID: 25880143 [TBL] [Abstract][Full Text] [Related]
53. Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model. Perche F; Patel NR; Torchilin VP J Control Release; 2012 Nov; 164(1):95-102. PubMed ID: 22974689 [TBL] [Abstract][Full Text] [Related]
54. Lymphoma Immunochemotherapy: Targeted Delivery of Doxorubicin via a Dual Functional Nanocarrier. Zhai Q; Chen Y; Xu J; Huang Y; Sun J; Liu Y; Zhang X; Li S; Tang S Mol Pharm; 2017 Nov; 14(11):3888-3895. PubMed ID: 28850241 [TBL] [Abstract][Full Text] [Related]
55. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy. Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128 [TBL] [Abstract][Full Text] [Related]
56. "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo. Xiao K; Li Y; Lee JS; Gonik AM; Dong T; Fung G; Sanchez E; Xing L; Cheng HR; Luo J; Lam KS Cancer Res; 2012 Apr; 72(8):2100-10. PubMed ID: 22396491 [TBL] [Abstract][Full Text] [Related]
57. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery. Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337 [TBL] [Abstract][Full Text] [Related]
58. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery. Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472 [TBL] [Abstract][Full Text] [Related]
59. Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer. Kutlehria S; Behl G; Patel K; Doddapaneni R; Vhora I; Chowdhury N; Bagde A; Singh M AAPS PharmSciTech; 2018 Feb; 19(2):792-802. PubMed ID: 29019073 [TBL] [Abstract][Full Text] [Related]
60. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells. Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]